Last updated on November 2005

Double-Masked Study of Photrex (Rostaporfin) Photodynamic Therapy in the Treatment of Age-Related Macular Degeneration


Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions: Macular Degeneration
  • Age: Between 50 - 100 Years
  • Gender: Male or Female
  • Other:
    Patients with age greater than or equal to 50 years with at least one subfoveal CNV
    membrane secondary to AMD that can be demonstrated by fluorescein angiography.

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.